Form 4 for NMTC NEUROONE MEDICAL TECHNOLOGIES Corp
Accepted 2026-01-05 00:00:00 ET · period of report 2025-12-31 · accession 0001540354-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-05 | 2025-12-31 | NMTC | Rosa David A | CEO, Pres, Dir | F - Tax | $0.76 | +2,458 | 1.15M | +0.2% | +$1,868 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-31 | F | A | 2,458 | $0.76 | 1,153,915 | D | — | — |